SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 231 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | -99.9% | 3,500 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | -28.6% | 3,500 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | -41.7% | 3,500 | -36.4% | 0.00% | – |
| Q1 2022 | $12,000 | -52.0% | 5,500 | 0.0% | 0.00% | – |
| Q4 2021 | $25,000 | -56.1% | 5,500 | -26.7% | 0.00% | – |
| Q3 2021 | $57,000 | -20.8% | 7,500 | 0.0% | 0.00% | – |
| Q2 2021 | $72,000 | +1.4% | 7,500 | -13.8% | 0.00% | – |
| Q1 2021 | $71,000 | +29.1% | 8,700 | +6.7% | 0.00% | – |
| Q4 2020 | $55,000 | +3.8% | 8,150 | +69.8% | 0.00% | – |
| Q3 2020 | $53,000 | +152.4% | 4,800 | +45.5% | 0.00% | – |
| Q2 2020 | $21,000 | +425.0% | 3,300 | +43.5% | 0.00% | – |
| Q1 2020 | $4,000 | -50.0% | 2,300 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | +60.0% | 2,300 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | – | 2,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Oaktree Fund Advisors, LLC | 66,000 | $503,000 | 48.93% |
| SABBY MANAGEMENT, LLC | 1,698,107 | $12,957,000 | 1.75% |
| EMFO, LLC | 233,008 | $1,778,000 | 1.57% |
| swisspartners Ltd. | 110,000 | $839,000 | 0.65% |
| HERITAGE WEALTH MANAGEMENT, LLC | 150,000 | $1,145,000 | 0.41% |
| Donald L. Hagan, LLC | 42,929 | $328,000 | 0.19% |
| COLLECTIVE FAMILY OFFICE LLC | 44,203 | $337,000 | 0.14% |
| Spectrum Wealth Advisory Group, LLC | 18,093 | $138,000 | 0.14% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 100,000 | $763,000 | 0.13% |
| Cormorant Asset Management, LP | 400,000 | $3,052,000 | 0.12% |